T he use of replication-deficient adenovirus vectors for the delivery of therapeutic genes to treat human disease has progressed rapidly in the last 10 years. [1] [2] [3] Adenovirus-mediated gene transfer into mammalian cells is attractive for a number of reasons. Foremost is the ability of adenovirus vectors to produce high levels of transgene expression compared with other established gene transfer methods, including retroviruses and cationic lipids. Adenovirus vectors can also deliver transgenes into a wide variety of cell types, with the notable exception of hematopoietic cells. 4, 5 Importantly, unlike retrovirus gene transfer vectors, nonreplicating as well as replicating cells are permissive of adenovirus transduction.
Limitations on the use of adenovirus-mediated gene transfer include vector immunogenicity and transient gene expression. Neutralizing antibodies and cytotoxic effector T cells, directed against both viral and transgene products, have been detected following in vivo administration of recombinant adenovirus vectors. 6, 7 Also, cytotoxic viral gene products can be expressed within transduced cells, further limiting transgene expression. 8 Our interest in polycation-enhanced adenovirus transduction stems from our goal of reducing adenovirus vector dosages in vivo. This approach is supported by data from gene therapy clinical trials that indicate that reducing virus vector doses can minimize or eliminate the adverse reactions associated with the administration of high adenovirus doses. 9 Polycations can be used in viral plaque assays to improve virion adsorption. The virus plaque assay is commonly used to quantify infectious virions in vitro. 10 Monolayer cultures of permissive mammalian cells are exposed to viral supernatants and overlayed with agarose or methylcellulose to facilitate focal viral replication. This technique depends upon efficient adsorption of the suspended virus onto the cell surface for accurate determinations of the number of infectious virions. Virus adsorption kinetics are affected by factors such as inoculum volume, adsorption time, and virus concentration. 10 Efforts to optimize viral adsorption kinetics, and thus improve assay accuracy, led researchers to experiment with culture additives to improve virion-cell interactions. Many common polycationic compounds have been tested in monolayer cultures and have been shown to improve virus adsorption and transduction efficiency for various mammalian viruses. [11] [12] [13] Two commonly used polycations in virus plaque assays are polybrene, or hexamethylbromide, and the cationic protein protamine sulfate. 13 In this paper, we describe the use of polycations to improve gene delivery for cancer gene therapy applications. We demonstrate the increased transgene expression and transduction efficiency of an E1-deleted, replication-deficient adenovirus vector using two polycationic compounds, polybrene and protamine sulfate. We further demonstrate that cationic lipids (N-(1-[2,3-dioleoyloxy]propyl)-N,N,N-trimethylammonium methylsulfate (DOTAP) and Lipofectamine) and a divalent cation (Ca 2ϩ , in the form of CaCl 2 ) enhance the transgene expression of replication-deficient adenovirus vectors in vitro.
MATERIALS AND METHODS

Reagents
Opti-MEM, RPMI 1640, Hanks' buffered salt solution (HBSS), Lipofectamine, and trypsin were obtained from Life Technologies (Gaithersburg, Md). Fetal bovine serum (FBS) and penicillin/streptomycin were purchased from Gemini BioProducts (Calabasas, Calif). Polybrene was obtained from Sigma (St. Louis, Mo), protamine sulfate from Lymphomed (Deerfield, Ill), and DOTAP from Boehringer Mannheim (Indianapolis, Ind).
Cell lines and tumor cell cultures
All established cell lines and primary tumor cultures were maintained in RPMI 1640 supplemented with 10% FBS, 100 U/mL penicillin, and 100 g/mL streptomycin (complete media (CM)). UM449, a human melanoma cell line, was generously provided by Dr. A. Chang (University of Michigan, Ann Arbor, Mich) and was used in all experiments unless otherwise indicated. Cell lines B16/F10 (murine melanoma), SW480 (colon carcinoma), HEY (ovarian carcinoma), A549 (lung adenocarcinoma), MCF-7 (breast adenocarcinoma), HL-60 (myeloid leukemia), and Daudi (lymphoma) were purchased from the American Type Culture Collection (Manassas, Va). MOT cells (a human T-lymphotrophic virus type II-transformed human T-cell line) were kindly provided by Dr. Paul Feorino (Centers for Disease Control and Prevention, Atlanta, Ga).
Primary tumor cultures were isolated from fresh human tumor tissue by enzymatic digestion. Briefly, fresh human tumors were minced in a sterile dish and washed with CM. Single cells were collected and treated for 1 hour at 37°C in a hypoosmotic medium, H3 (0.8% FBS, 5% polyvinylpyrrolidone-40 (Sigma), 2% carboxy methyl cellulose (Sigma), and 0.1% ethylenediaminetetraacetic acid (Sigma)) prior to culture in CM. Tumor fragments were incubated with 1.5 U collagenase A (Boehringer Mannheim), 1600 U deoxyribonuclease I (Sigma), and 2000 U hyaluronidase (Sigma) for 2-4 hours at 37°C, centrifuged at 300 ϫ g, and plated in CM overnight. Nonadherent cells were removed the following day, and fresh medium was added. Primary cultures were maintained for 2-21 days.
Animals and tumors
We purchased 6-to 10-week-old severe combined immunodeficient (SCID) (C.B-17 scid/scid) mice from the University of Arizona Animal Care Facility; mice were housed in microisolator cages. UM449 cells were trypsinized and collected during log growth, washed, and resuspended in HBSS. Bilateral, subcutaneous (s.c.) tumors were established by injecting 1 ϫ 10 6 UM449 cells into the flanks of SCID mice.
In vitro adenovirus transduction
Cells were seeded into 96-well plates at 2 ϫ 10 4 cells/well and incubated overnight at 37°C. Ad5/⌬E1(CMV-LacZ) (Ad5/ LacZ), an E1-deleted adenovirus containing the Escherichia coli ␤-galactosidase (␤-gal) gene (lacZ) under the control of the cytomegalovirus immediate/early promotor, was provided by Cell Genesys (Foster City, Calif). Virus was diluted in Opti-MEM with 2% FBS to achieve a 2ϫ virus dilution. Polycations and cationic lipids were similarly diluted into Opti-MEM with 2% FBS to yield 2ϫ dilutions. Virus and cation mixtures were combined at a 1:1 ratio and allowed to incubate for 15 minutes at room temperature. Cell monolayers were washed with HBSS and overlayed with 0.05 mL of virus/cation mixture. After 2 hours at 37°C, the medium was removed. The cell monolayer was washed with HBSS and incubated in complete RPMI 1640 for an additional 22 hours in culture prior to analysis for ␤-gal expression.
Cells from individual wells were lysed by the addition of 0.15 mL of 0.05% Triton X-100/phosphate-buffered saline. Cell lysate (0.05 mL) was transferred to flat-bottom, 96-well plates. Following the addition of 0.15 mL of a 1 mg/mL CPRG (chlorophenol red-␤-D-galactopyranoside; Sigma), ␤-gal enzyme activity was detected by spectrophotometry at 595 nm. A standard curve using known values of ␤-gal was generated with each experiment. Protein content for each lysate was determined using the bicinchoninic acid (BCA) protein assay reagent kit (Pierce, Rockford, Ill).
In vivo transduction
Prior to tumor injection, individual animals were anesthetized using a cocktail of ketamine HCl (Mallinckrodt, Mundelein, Ill), xylazine, and acepromazine maleate (The Butler Company, Columbus, Ohio). Ad5/LacZ was admixed with protamine sulfate in saline at the indicated concentrations immediately prior to intratumoral (i.t.) injection. Eight-day-old tumors (0.5-1.0 cm) were injected with 0.05 mL of virus mixture using a 27-gauge needle. Individual injections were performed as a single injection site, with care being taken to distribute the inoculum within the tumor. At 48 hours postinjection, the animals were anesthetized with halothane (Halocarbon Laboratories, River Edge, NJ) and sacrificed by cervical dislocation. Tumors were excised, minced, and incubated for 3-4 hours at 37°C in complete RPMI 1640 supplemented with collagenase A (1 g/mL) and deoxyribonuclease I (0.02%) to yield singlecell tumor suspensions.
Statistical analysis
Using the Instat statistical program (GraphPad Software, San Diego, Calif), analysis of variance (ANOVA) was used to determine the difference between groups and the Dunnett multiple comparisons test was used to test for statistical significance. An unpaired, two-tailed Student's t test was used to determine differences between the means of two groups. Significance was considered at P Ͻ .05. 
RESULTS
Polycations and cationic lipids increase in vitro adenovirus transgene expression and transduction efficiency
We admixed polycationic compounds with Ad5/LacZ, a replication-deficient adenovirus vector containing the ␤-gal gene, to determine whether transgene expression could be improved. Transducing UM449 cells with mixtures of Ad5/LacZ and polybrene or protamine sulfate enhanced in vitro ␤-gal transgene expression in a dosedependent manner. Polybrene, at 10 g/mL, improved transgene expression by 6-fold; protamine sulfate, at 200 g/mL, enhanced transgene expression by 3.3-fold ( Fig  1, a and b ). The addition of polybrene also increased the percentage of UM449 cells transduced, from 8.4% to 35.5% at a multiplicity of infection (MOI) of 1 and from 70.4% to 94.7% at an MOI of 10 (Fig 2a) , or a 4.2-and 1.3-fold increase, respectively. Under the same conditions, transgene expression improved by 4.2-and 4.4-fold, respectively (Fig 2b) . At optimal polycation concentrations, we did not detect any overt cytotoxicity using light microscopy or changes in protein content (data not shown).
We also tested the activity of cationic lipids in enhancing adenovirus transduction. Lipofectamine and DOTAP both augmented transgene expression (Fig 1, c and d) . Compared with adenovirus vector alone, Lipofectamine produced a 9.6-fold increase in transgene expression, whereas DOTAP yielded a 3.7-fold increase in ␤-gal expression. As with polybrene and protamine sulfate, cationic lipids did not produce cytotoxicity when used at their optimum concentrations (data not shown).
We also evaluated the activity of Ca 2ϩ , in the form of CaCl 2 , on adenovirus transduction. The addition of 62.5 mM CaCl 2 to Ad5/LacZ resulted in a 5.5-fold increase in ␤-gal expression over vector alone (Fig 1e) . However, this treatment produced significant cellular toxicity, resulting in a 40% reduction in total cell protein. CaCl 2 at 31.25 mM produced a 3.5-fold increase in ␤-gal expression and did not result in significant cytotoxicity (data not shown).
To determine whether polybrene could reliably increase transgene expression in human tumors, additional established tumor cell lines were tested. Six adherent tumor cell lines were exposed to Ad5/LacZ admixed with 5 g/mL polybrene (MOI ϭ 10). Adenovirusmediated transgene expression was significantly improved by the addition of polybrene in four of the six tested lines, including two melanoma cell lines ( Table 1 ). The addition of polybrene was not universally beneficial, as SW480 (human colon cancer) and A249 (human lung cancer) were unaffected by polybrene addition. In three nonadherent, hematopoietic cell lines (HL-60, Daudi, and MOT), both polybrene and protamine sulfate were effective at improving adenovirus transgene expression (Table 2) . Of particular note, HL-60 cells, which express little or no ␤-gal in the absence of polycations, produced substantial amounts of transgene product when transduced with protamine sulfate.
To determine whether polycations could also enhance adenovirus transduction for gene therapy protocols, primary tumor cultures were tested in vitro. Five primary tumor cultures (in culture for 3-21 days) were exposed to adenovirus vector in the presence or absence of polycationic compounds. Protamine sulfate and DOTAP admixed with Ad5/LacZ were particularly effective at enhancing transgene expression in primary tumors com- pared with vector alone (Table 3 ). All five primary tumors displayed some level of enhanced transgene expression using polycationic compounds. In addition, patient leukemic cells were cultured for 2 or 3 days and transduced with Ad5/LacZ in the presence or absence of 5 g/mL polybrene. The percentage of positive (blue) cells was consistently higher when polybrene was added, with transduction efficiencies increasing by 1.2-to 4.4-fold (mean ϭ 2.34) ( Table 4) .
Polycations improve adenovirus adsorption to tumor cells
Others have shown that in vitro plaque formation is improved for a variety of viruses following the addition of polycationic compounds. [11] [12] [13] These studies have suggested that polycations function as "electrostatic bridges", overcoming the repulsion of negatively charged eucaryotic cell membranes and negatively charged do- mains on infecting virions. We have performed experiments to evaluate the factors affecting enhanced adenovirus transduction. Virus adsorption, as reflected by transgene expression, increases with time and is improved by the presence of polybrene (Fig 3) . The augmentation of gene expression by polybrene is most pronounced when using short adsorption times and diluted virus suspensions (data not shown). Further, Ad5/LacZ transduction in the presence of polybrene is durable, because cultured UM449 cells express the ␤-gal transgene at elevated levels for Ն8 days (Fig 4) . We further investigated whether polycationic compounds were required to be present during virus adsorption for expression enhancement. Cells that were transduced with Ad5/LacZ, washed, and subsequently treated with polybrene did not show increased transgene expression compared with cells transduced with vector alone (Fig 5) . Others have reported that pretreating cells with cationic compounds is sufficient to augment virus infectivity; 13 however, we were unable to reproduce these findings by pretreating cells with polybrene (data not shown). Our results indicate that polycation must be present during virus adsorption to enhance gene transfer.
As we intend to adapt polycation-enhanced transduction to an in vivo, xenogeneic murine tumor model, we tested whether charged serum components would adversely affect adenovirus transduction. 14 We transduced UM449 cells with Ad5/LacZ formulated in either 2% or 50% FBS. A substantial decrease in transgene expression was observed in the presence of 50% FBS (Fig 6) . The addition of high concentrations of polybrene or protamine sulfate reversed the negative effects of sera. In the presence of 50% FBS, optimal transgene expression was achieved by supplying an additional 8-to 32-fold of polybrene and 8-to 16-fold of protamine sulfate compared with the optimal amounts required when using 2% FBS. We observed a linear relationship between the level of serum increase (25-fold) and the amounts of polybrene (8-to 32-fold) and protamine sulfate (8-to 16-fold) required to re-establish vector transgene expression. This association between polycation and serum concentrations may reflect the need for increased polycation to neutralize the inhibitory, anionic compounds present in sera.
Protamine sulfate does not augment adenovirus transduction following i.t. injection The effect of protamine sulfate on i.t. adenovirus gene transfer was evaluated using s.c. UM449 tumors in SCID mice. Ad5/LacZ was admixed with protamine sulfate at three different concentrations. The protamine sulfate concentrations were selected based on in vitro transduction studies with high serum culture conditions. Established tumors were injected with a total of 2.5 ϫ 10 7 plaque-forming units (PFU) Ad5/LacZ formulated with or without protamine sulfate. Significant levels of ␤-gal expression were detected in all tumor groups receiving Ad5/LacZ (Fig 7) . In two separate experiments, the addition of protamine sulfate did not significantly effect the level of transgene expression compared with virus alone. The i.t. transduction efficiency was similarly unaffected as determined by 5-bromo-4-chloro-3-indolyl ␤-D-galactoside (X-Gal) staining of tumor cells from disaggregated tumors (data not shown).
DISCUSSION
The precise mechanism of action for polycation-enhanced adenovirus transduction remains unclear. The simplest explanation for this observed phenomenon is that polycationic compounds serve as electrostatic bridges between virus and target cells. Mammalian cells possess significant negative surface charge due to glycosylated phospholipids on cell membranes, 15, 16 and mammalian viruses, in general, exhibit a net negative charge at physiologic pH. 17 Through empirical experimentation, investigators have concluded that polycationic compounds added during virus adsorption diminish electrostatic repulsion between negatively charged mammalian cells and eucaryotic viruses. 13, 18 Viruses reported to benefit from polycation addition include herpes virus, echovirus, Rous sarcoma virus, orthomyxovirus, and an adenovirus. 12 When prepared in the proper charge ratios, poly(L)-lysine forms noncovalent complexes with adenovirus vectors 19 to produce a net positive charge that may favor adenovirus-cellular interactions. Similar complexes would be anticipated if adenovirus particles were admixed with other polycationic compounds (i.e., cationic lipids).
An alternate explanation for the positive effects of polycations on adenovirus transduction may be the neutralization of inhibitory macromolecules present in agar overlays or sera. It is known that anionic glycoconjugates, such as sulfonated polysaccharides 16 and sialic acid, 15 inhibit virus infection and replication. In fact, natural and semisynthetic anionic carbohydrates are being evaluated as new antiviral compounds. 20 Polycationic compounds, when added to virus cultures, may act by saturating anionic binding sites that would normally inactivate free virus. An inhibitory effect from serum components is suggested by our findings, which reveal that polybrene or protamine sulfate, when added to virus cultures, reverses the negative effect of high sera (Fig 6) .
Polycation treatment may also affect cellular metabolism or induce alterations in cellular membranes leading to improved transgene expression. Our data do not support this position, as we were unable to show significant increases in adenovirus transgene expression when cells were pretreated or posttreated with polybrene ( Fig  5) . This observation, together with the fact that enhanced transgene expression is maintained for 8 days after polycation treatment (Fig 4) , argues that transient metabolic or physiologic effects due to polycationic treatment are not responsible for transgene expression increases.
The original aim of this study was to develop a strategy for minimizing the adverse effects of in vivo administration of adenovirus vectors by reducing vector doses. Preclinical trials with replication-deficient adenovirus have revealed that host cell-mediated and humoral immune responses can interfere with infection after repeated vector administrations and limit the duration of adenovirus-mediated transgene expression. 6, 7 One study reported peribronchiolar and perivascular infiltration after an intratracheal injection of 10 10 and 10 9 PFU of adenovirus particles. These pathologies were absent when 10 8 PFUs were administered, 9 indicating that reduced adenovirus dosing may improve the success of gene therapy protocols. Also, reducing vector doses may have the added benefit of minimizing neutralizing antibody production. Finally, reducing the levels of adenovirus vector in gene therapy protocols would have a substantial impact on the cost of conducting gene therapy trials.
Encephalomyocarditis virus, when admixed with polybrene and injected s.c., resulted in increased virus replication and spread into surrounding tissues and blood. 11 When administered with polycations in the same system, however, Coxsackie and Sindbis viruses were no more virulent to tissues than virus alone. More recently, poly(L)-lysine-complexed adenovirus vector, containing the murine cystic fibrosis transmembrane conductance regulator gene homolog, was more effective at correcting pulmonary electrophysiologic defects in ⌬F/⌬F mice than vector alone. 19 Polycations have also been shown to improve adenovirus transgene expression in cultured epithelial and endothelial cells. 21, 22 These reports have speculated that polycations might improve infection/ transduction efficiency when coadministered with virus preparations at s.c. and intrapulmonary sites. Effect of polybrene treatment following virus adsorption. UM449 cells were transduced with Ad5/LacZ at an MOI of 10 with or without 5 g/mL polybrene. Virus supernatant was removed after 1 hour, and the cell monolayer was washed with HBSS, treated with media alone or with media supplemented with 5 g/mL polybrene, and incubated for a total of 24 hours. Cells were then collected, lysed, and analyzed for ␤-gal expression and protein content. The experiment was performed twice, and a representative experiment is shown. Figure 6 . Transduction inhibition by 50% FBS and reversal using polybrene and protamine sulfate. Ad5/LacZ was prepared in media containing either 2% or 50% FBS and was used to transduce UM449 cells. Ad5/LacZ was also formulated in 50% FBS supplemented with the indicated concentrations of polybrene or protamine sulfate. Cells were transduced (with or without polycations) at an MOI of 10 for 2 hours, incubated for 24 hours, and analyzed for ␤-gal enzyme activity and protein content. The experiment was performed twice, and a representative experiment is shown.
Limitations on the use of polycations to enhance adenovirus transduction in vivo are hard to predict. Polycationic agents may produce unanticipated consequences. For example, polybrene, when coinjected with encephalomyocarditis virus, increased interferon production in tissues and blood of inoculated mice; 11 however, this effect was absent when uninfected animals were treated with polybrene. In the same study, mononuclear cell infiltration was observed in animals due to diethylaminoethyl-dextran injections alone. The use of polycationic compounds might also inhibit the spread of virus particles within tumors and deep tissues through "electrostatic tethering" of virus-polycation complexes to anionic extracellular matrices.
We investigated whether protamine sulfate-adenovirus complexes increase ␤-gal transgene expression following direct i.t. injection of UM449 tumors. Our studies failed to show an increase in transgene expression or transduction efficiency (Fig 7) . Recently, another group also found that cationic lipid/␤-gal-expressing adenovirus mixtures infused into balloon-injured rat carotid arteries did not increase transgene expression. 22 Further studies may reveal other polycations to be superior for i.t. applications. Tissue type and location as well as the presence or absence of serum components may further influence the outcome of polycation-adenovirus complex injection. The administration of virus-polycation complexes into s.c. or intranasal spaces may achieve a better response than direct injection into solid tumors, where tissue penetration of large complexes may be restricted.
In summary, this study provides evidence that in vitro adenovirus transduction efficiency is improved in established and primary tumor cells by the addition of polycations, cationic lipids, and CaCl 2 . Simple manipulations of adenovirus formulations may result in substantial improvements in viral gene transfer efficiencies. were lysed using a Triton X-100 buffer and freeze/thawing. Cell lysates were evaluated for ␤-gal transgene expression and protein content. The graph represents pooled mean data (Ϯ SEM) from two identical trials with the total number of tumors per group: n ϭ 10, 9, 10, 9, and 4, respectively, P Ͼ.5 (not significant).
